Eckert & Ziegler SEXTER:EUZ -0.65%98 OCF Margin % is 7.09% as of Mar. 2026, which is 63% below its 10-year median of 19.01. GuruFocus rates XTER:EUZ with a GF Score™ of 98/100 and a GF Value™ of €16.25 (Fairly Valued). Among 815 Medical Devices & Instruments companies, Eckert & Ziegler SE ranks better than 73.74% on this metric.
The historical rank and industry rank for Eckert & Ziegler SE's OCF Margin % or its related term are showing as below:
XTER:EUZ'
s OCF Margin % Range Over the Past 10 Years
Min: 12.57 Med: 19.01 Max: 22.65
Current: 17.88
During the past 13 years, the highest OCF Margin % of Eckert & Ziegler SE was 22.65%. The lowest was 12.57%. And the median was 19.01%.
XTER:EUZ's OCF Margin % is ranked better than 73.74% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs XTER:EUZ: 17.88
Eckert & Ziegler SE OCF Margin % Related Terms
Eckert & Ziegler SE OCF Margin % Historical Data
* Premium members only.
The historical data trend for Eckert & Ziegler SE's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:EUZ vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Eckert & Ziegler SE's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eckert & Ziegler SE OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Eckert & Ziegler SE's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eckert & Ziegler SE (XTER:EUZ) has a OCF Margin % of 7.09% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eckert & Ziegler SE and its competitors. This is 63% below median its historical median of 19.01. Over the past decade, Eckert & Ziegler SE's OCF Margin % has ranged from 12.57 to 22.65. According to the industry distribution chart, Eckert & Ziegler SE ranks #214 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 26.3%.
Is Eckert & Ziegler SE's OCF Margin % too high?
Eckert & Ziegler SE's current OCF Margin % of 7.09% is 63% below median its 10-year median of 19.01. Over the past 10 years, this metric has ranged from a low of 12.57 to a high of 22.65. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Eckert & Ziegler SE's value of 7.09% is 21% above this industry median. Based on the distribution chart, Eckert & Ziegler SE ranks #214 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Eckert & Ziegler SE has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eckert & Ziegler SE's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eckert & Ziegler SE ranks #214 out of 815 companies for OCF Margin %. This puts Eckert & Ziegler SE in the upper half of its industry. The industry median OCF Margin % is 5.86. Eckert & Ziegler SE's value of 7.09% is 21% above this benchmark. Historically, Eckert & Ziegler SE's own OCF Margin % has ranged from 12.57 to 22.65 over the past decade. While the company's 10-year median is 19.01 vs. the industry median of 5.86, Eckert & Ziegler SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eckert & Ziegler SE's current OCF Margin % of 7.09% is 21% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eckert & Ziegler SE and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eckert & Ziegler SE's current OCF Margin % is 7.09%, which is 63% below median its own 10-year median of 19.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eckert & Ziegler SE stock overvalued right now?
Based on GuruFocus' analysis, Eckert & Ziegler SE (XTER:EUZ) is currently considered Fairly Valued. The stock's GF Value™ is €16.25, compared to a current price of €15.31 — trading 5.8% below its estimated fair value. The current OCF Margin % is 7.09%, which is 63% below median its 10-year median of 19.01 and 21% above the Medical Devices & Instruments industry median of 5.86. Eckert & Ziegler SE's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Eckert & Ziegler SE (XTER:EUZ), the current OCF Margin % is 7.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eckert & Ziegler SE (XTER:EUZ) Overvalued in 2026?
Based on GuruFocus' analysis, Eckert & Ziegler SE stock appears to be undervalued.
The current stock price of €15.31 is trading 5.8% below its estimated GF Value™ of €16.25.
GuruFocus considers Eckert & Ziegler SE to be Fairly Valued.
Key valuation signals for XTER:EUZ:
OCF Margin %: 7.09% (63% below median its 10-year median of 19.01)
GF Value™: €16.25 vs. price of €15.31 (5.8% below fair value)
Industry Position: 21% above the Medical Devices & Instruments median (#214 of 815)
No single metric tells the full story. See the XTER:EUZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.
98GF Score
Get the complete analysis for XTER:EUZ
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:EUZ has been successfully added to your 
